M
Medicofarma Biotech SA
WSE:MDB
Medicofarma Biotech SA
WSE:MDB
Price:
0.44
PLN
7.06%
Market Closed
Market Cap:
zł29.9m
Income Statement
Earnings Waterfall
Medicofarma Biotech SA
Medicofarma Biotech SA
Income Statement
Medicofarma Biotech SA
Medicofarma Biotech SA
Currency: PLN
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
6
N/A
|
6
-8%
|
9
+58%
|
4
-52%
|
5
+14%
|
5
-4%
|
1
-74%
|
1
-37%
|
1
+81%
|
1
+1%
|
1
-22%
|
1
+14%
|
0
-62%
|
0
-40%
|
|
| Gross Profit | |||||||||||||||
| Cost of Revenue |
(4)
|
(4)
|
(7)
|
(3)
|
(3)
|
(3)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Gross Profit |
2
N/A
|
1
-24%
|
2
+27%
|
1
-35%
|
1
+35%
|
1
+2%
|
1
-30%
|
0
-52%
|
1
+117%
|
1
+6%
|
1
-40%
|
1
+56%
|
0
-86%
|
0
-30%
|
|
| Operating Income | |||||||||||||||
| Operating Expenses |
(2)
|
(3)
|
(5)
|
(3)
|
(4)
|
(3)
|
(2)
|
(4)
|
(4)
|
(4)
|
(4)
|
(3)
|
(3)
|
(3)
|
|
| Selling, General & Administrative |
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Depreciation & Amortization |
(1)
|
(2)
|
(3)
|
(2)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(2)
|
|
| Other Operating Expenses |
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
|
| Operating Income |
(1)
N/A
|
(2)
-152%
|
(3)
-66%
|
(2)
+51%
|
(2)
-44%
|
(2)
+13%
|
(1)
+42%
|
(3)
-201%
|
(3)
+16%
|
(3)
+4%
|
(3)
-16%
|
(2)
+36%
|
(3)
-34%
|
(3)
-7%
|
|
| Pre-Tax Income | |||||||||||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
(1)
N/A
|
(2)
-150%
|
(3)
-66%
|
(2)
+51%
|
(2)
-44%
|
(2)
+12%
|
(1)
+41%
|
(4)
-208%
|
(3)
+15%
|
(3)
+5%
|
(3)
-15%
|
(2)
+31%
|
(3)
-30%
|
(3)
-7%
|
|
| Net Income | |||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(1)
|
(2)
|
(3)
|
(2)
|
(2)
|
(2)
|
(1)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(3)
|
(3)
|
|
| Net Income (Common) |
(1)
N/A
|
(2)
-151%
|
(3)
-66%
|
(2)
+50%
|
(2)
-44%
|
(2)
+12%
|
(1)
+41%
|
(3)
-190%
|
(3)
+16%
|
(3)
+5%
|
(3)
-16%
|
(2)
+27%
|
(3)
-31%
|
(3)
-7%
|
|
| EPS (Diluted) |
-0.01
N/A
|
-0.03
-200%
|
-0.05
-67%
|
-0.02
+60%
|
-0.03
-50%
|
-0.03
N/A
|
-0.02
+33%
|
-0.05
-150%
|
-0.04
+20%
|
-0.04
N/A
|
-0.05
-25%
|
-0.03
+40%
|
-0.04
-33%
|
-0.04
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
